A pioneering five-year research programme to develop the foundational tools for synthesising human genomes has launched with £10mn funding from Wellcome. The ambitious Synthetic Human Genome project, led by Professor Jason Chin at the MRC Laboratory of Molecular Biology, aims to unlock transformative biotechnology applications and accelerate targeted cell-based therapies.
Healthcare technology strategist Melinda Yormick explores how real-time data integration represents a critical breakthrough in hospital operational efficiency. Her analysis reveals how precision operations – enabled by automated workflow monitoring and live analytics – could transform fragmented healthcare systems into coordinated, responsive care environments, fundamentally improving patient outcomes and resource allocation across critical departments.
Researchers have assembled the most comprehensive genetic atlas of cannabis to date, revealing unprecedented molecular diversity that could revolutionise medicinal applications and unlock novel therapeutic compounds. The landmark study, published in Nature on 28 May 2025, analysed 193 cannabis genomes and identified surprising genetic variation that may hold the key to developing new cannabinoid-based treatments.
In a Genomic Psychiatry interview, Professor Barbara Franke reveals how her revolutionary interdisciplinary approach is transforming ADHD research. Her innovative methodology combines cutting-edge genomics, experimental models, and international collaboration to decode biological pathways from genetic variations to behavioural changes, offering unprecedented insights for personalised neurodevelopmental treatments.
Healthcare expenditure escalates globally at rates dramatically exceeding GDP growth, creating an unsustainable affordability crisis that demands urgent technological transformation and innovative financing solutions, according to Penny Pinnock from Siemens Financial Services, who examines new analysis of eight-year spending trends across international health systems.
As artificial intelligence becomes increasingly sophisticated in mimicking human interaction, psychologists warn that intimate relationships with AI companions present significant ethical challenges ranging from disruption of human bonds to potential manipulation and exploitation of vulnerable users.
A comprehensive evaluation of a green social prescribing programme in northern England has demonstrated that connecting people with nature-based activities can significantly improve mental health outcomes within just 12 weeks. The findings, published 16 April 2025 in Health & Social Care in the Community, highlight the potential for nature-based interventions to serve as effective therapeutic […]
Sleep works as the body’s natural reset – a time for the mind to recharge and the body to restore itself. Yet, for millions suffering from obstructive sleep apnea (OSA), restful sleep remains elusive. Instead of renewal, they endure interrupted breathing and fragmented rest, leading to an increased risk of serious health issues.
As global health authorities tackle with a host of established infectious disease threats, a previously obscure virus is steadily expanding its reach beyond its traditional Amazonian stronghold. Oropouche virus, first identified in Trinidad and Tobago in 1955, has emerged as a significant public health concern across South America and the Caribbean, with recent outbreaks reported […]
Climate change is rapidly altering health outcomes worldwide, yet medical and public health responses remain insufficiently evidence-based, according to researchers from the University of Washington. Their analysis, published March 10 in JAMA, highlights critical gaps in understanding and addressing climate-related health effects and calls for a more systematic approach to building resilience in healthcare systems. […]
Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@interhospi.com
PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.
Salk Institute
Barbara Franke, PhD